Open access
Sep 2026
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma
P. Sudalagunta, Filip Ionescu, R. Canevarolo et al.
· medRxiv · 0 citations